ENTITY

Chimeric Therapeutics (CHM AU)

8
Analysis
Health Care • Australia
Chimeric Therapeutics Limited operates as a biotechnology company. The Company develops CAR T cell therapies for solid tumors based on research at the City of Hope Cancer Centre in Los Angeles. Chimeric Therapeutics serves customers worldwide.
more
bullish•Chimeric Therapeutics
•09 Sep 2022 08:00•Issuer-paid

Chimeric Therapeutics Limited - Assembling a World-Class Team, Partners and Assets

Chimeric Therapeutics Limited Assembling a world-class team, partners and assets Chimeric Therapeutics Limited (ASX:CHM) is a...

Share
bullish•Chimeric Therapeutics
•03 Mar 2022 08:00•Issuer-paid

Chimeric Therapeutics Ltd - Entitlement Offer to Raise up to $18.1M

Chimeric Therapeutics Ltd Entitlement offer to raise up to $18.1M Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company...

Share
bullish•Chimeric Therapeutics
•09 Feb 2022 08:00•Issuer-paid

Chimeric Therapeutics Ltd: Hitting Milestones and Pipeline Flowing

Chimeric Therapeutics Ltd Hitting milestones and pipeline flowing Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company...

Share
bullish•Chimeric Therapeutics
•17 Dec 2021 08:00•Issuer-paid

Chimeric Therapeutics Ltd: Adding to the Pipeline with a Clinical Platform Technology

Chimeric Therapeutics Ltd Adding to the pipeline with a clinical platform technology Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell...

Share
bullish•Chimeric Therapeutics
•06 Dec 2021 16:20•Issuer-paid

Chimeric Therapeutics - Acquiring an exciting new NK cell technology

Chimeric has announced that it has entered into an exclusive option agreement to license the clinically validated, off the shelf, robust, enhanced...

Share
x